<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicines (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Medicines (Basel)</journal-id><journal-id journal-id-type="publisher-id">medicines</journal-id><journal-title-group><journal-title>Medicines</journal-title></journal-title-group><issn pub-type="epub">2305-6320</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7555937</article-id><article-id pub-id-type="doi">10.3390/medicines7090057</article-id><article-id pub-id-type="publisher-id">medicines-07-00057</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Cannabidiol Content and In Vitro Biological Activities of Commercial Cannabidiol Oils and Hemp Seed Oils</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kitamura</surname><given-names>Masashi</given-names></name><xref ref-type="aff" rid="af1-medicines-07-00057">1</xref><xref rid="c1-medicines-07-00057" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Kiba</surname><given-names>Yuka</given-names></name><xref ref-type="aff" rid="af1-medicines-07-00057">1</xref></contrib><contrib contrib-type="author"><name><surname>Suzuki</surname><given-names>Ryuichiro</given-names></name><xref ref-type="aff" rid="af1-medicines-07-00057">1</xref></contrib><contrib contrib-type="author"><name><surname>Tomida</surname><given-names>Natsumi</given-names></name><xref ref-type="aff" rid="af2-medicines-07-00057">2</xref></contrib><contrib contrib-type="author"><name><surname>Uwaya</surname><given-names>Akemi</given-names></name><xref ref-type="aff" rid="af2-medicines-07-00057">2</xref></contrib><contrib contrib-type="author"><name><surname>Isami</surname><given-names>Fumiyuki</given-names></name><xref ref-type="aff" rid="af2-medicines-07-00057">2</xref></contrib><contrib contrib-type="author"><name><surname>Deng</surname><given-names>Shixin</given-names></name><xref ref-type="aff" rid="af3-medicines-07-00057">3</xref></contrib></contrib-group><aff id="af1-medicines-07-00057"><label>1</label>Laboratory of Pharmacognocy, School of Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1&#x02013;1, Keyakidai, Sakado, Saitama 350-0295, Japan; <email>yy17087@josai.ac.jp</email> (Y.K.); <email>ryu_suzu@josai.ac.jp</email> (R.S.)</aff><aff id="af2-medicines-07-00057"><label>2</label>Research and Development, Morinda Worldwide, Inc., Morinda Bldg., 3-2-2 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan; <email>Natsumi_Tomida@jp.morinda.com</email> (N.T.); <email>akemi_uwaya@jp.morinda.com</email> (A.U.); <email>fumiyuki_isami@jp.morinda.com</email> (F.I.)</aff><aff id="af3-medicines-07-00057"><label>3</label>Research and Development, Morinda Inc., 737 East 1180 South, American Fork, UT 84003, USA; <email>Shixin_Deng@newage.com</email></aff><author-notes><corresp id="c1-medicines-07-00057"><label>*</label>Correspondence: <email>kitamura@josai.ac.jp</email>; Tel.: +81-49-271-8021</corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>9</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2020</year></pub-date><volume>7</volume><issue>9</issue><elocation-id>57</elocation-id><history><date date-type="received"><day>28</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>04</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><bold>Background:</bold> Hemp (<italic>Cannabis sativa</italic> L.) seed contains high contents of various nutrients, including fatty acids and proteins. Cannabidiol (CBD) is a non-psychoactive compound that can be extracted from <italic>C. sativa</italic> and used for treating epilepsy and pain. Industrial hemp products, including CBD and hemp seed oils, have become increasingly popular. Some products are marketed without a clear distinction between CBD and hemp seed oils. Herein, the CBD content and biological activities of commercial CBD and hemp seed oils were examined. <bold>Methods:</bold> CBD content was measured by high-performance liquid chromatography. For in vitro antioxidant activity determination, 2,2-diphenyl-1-picrylhydrazyl and 2,2&#x02032;-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) radical-scavenging assays were performed. <bold>Results:</bold> The CBD concentrations in the two CBD oil samples were 18.9 &#x000b1; 0.5 and 9.2 &#x000b1; 0.4 mg/mL. Of the seven hemp seed oil samples, six samples contained CBD in concentrations ranging from 2.0 &#x000b1; 0.1 to 20.5 &#x000b1; 0.5 &#x000b5;g/mL, but it was not detected in one sample. Antioxidant activity was observed in both CBD oil samples. <bold>Conclusions:</bold> The results indicate that (1) CBD content varied by hemp seed oil sample and that (2) antioxidant activity could be a useful landmark for discriminating CBD oils from hemp seed oils.</p></abstract><kwd-group><kwd>Cannabidiol</kwd><kwd>hemp</kwd><kwd>antioxidant</kwd><kwd><italic>Cannabis sativa</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-medicines-07-00057"><title>1. Introduction</title><p><italic>Cannabis sativa</italic> L. has been cultivated worldwide for centuries for medicinal, industrial and recreational use. The characteristic compounds of <italic>C. sativa</italic> L. are cannabinoids, including delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD) [<xref rid="B1-medicines-07-00057" ref-type="bibr">1</xref>]. THC is the main psychoactive compound, whereas CBD is non-psychoactive and can effectively treat epilepsy and other neuropsychiatric disorders [<xref rid="B2-medicines-07-00057" ref-type="bibr">2</xref>,<xref rid="B3-medicines-07-00057" ref-type="bibr">3</xref>,<xref rid="B4-medicines-07-00057" ref-type="bibr">4</xref>,<xref rid="B5-medicines-07-00057" ref-type="bibr">5</xref>,<xref rid="B6-medicines-07-00057" ref-type="bibr">6</xref>,<xref rid="B7-medicines-07-00057" ref-type="bibr">7</xref>,<xref rid="B8-medicines-07-00057" ref-type="bibr">8</xref>]. Therefore, an increasing number of CBD products have been marketed worldwide. Commercial CBD products are primarily produced from industrial <italic>C. sativa</italic> or hemp, which contains little or no THC [<xref rid="B9-medicines-07-00057" ref-type="bibr">9</xref>,<xref rid="B10-medicines-07-00057" ref-type="bibr">10</xref>]. Hemp seed is often utilized as a functional food and medicine. In Kampo medicine, it is known as Mashinin, and is used as a laxative [<xref rid="B11-medicines-07-00057" ref-type="bibr">11</xref>]. Hemp seed oil contains &#x0003e;80% polyunsaturated fatty acids with two essential fatty acids, i.e., linoleic acid (18:2 omega-6) and alpha-linolenic acid (18:3 omega-3) [<xref rid="B12-medicines-07-00057" ref-type="bibr">12</xref>]. The omega-6 to omega-3 ratio in hemp seed oil is considered to be nutritionally optimal [<xref rid="B9-medicines-07-00057" ref-type="bibr">9</xref>,<xref rid="B10-medicines-07-00057" ref-type="bibr">10</xref>,<xref rid="B12-medicines-07-00057" ref-type="bibr">12</xref>]. Some reports have demonstrated that cannabinoids can be detected in commercial hemp seed products [<xref rid="B12-medicines-07-00057" ref-type="bibr">12</xref>,<xref rid="B13-medicines-07-00057" ref-type="bibr">13</xref>]. Considering that hemp seed produces no cannabinoids in its metabolic pathways, it could be contaminated with resin from the flowers and leaves, which contain cannabinoids, during hemp seed processing [<xref rid="B12-medicines-07-00057" ref-type="bibr">12</xref>,<xref rid="B13-medicines-07-00057" ref-type="bibr">13</xref>,<xref rid="B14-medicines-07-00057" ref-type="bibr">14</xref>].</p><p>Few reports have been published on the CBD quantification of CBD oil products marketed in Japan, or on the existence of CBD in hemp seed oils commercially available in Japan. In addition, some products are marketed without a clear distinction between CBD and hemp seed oils. Essential oil obtained from hemp is commonly studied using a multidisciplinary approach for evaluating various biological activities, including antioxidant capacity, enzyme inhibition, antimicrobial activity and cytotoxicity on cell lines [<xref rid="B15-medicines-07-00057" ref-type="bibr">15</xref>,<xref rid="B16-medicines-07-00057" ref-type="bibr">16</xref>,<xref rid="B17-medicines-07-00057" ref-type="bibr">17</xref>]. CBD has demonstrated strong antioxidant effects and can be considered a potent neuroprotective agent [<xref rid="B8-medicines-07-00057" ref-type="bibr">8</xref>,<xref rid="B18-medicines-07-00057" ref-type="bibr">18</xref>]. Therefore, in vitro biological assays might be useful for discriminating CBD oils from hemp seed oils. Herein, commercially available CBD and hemp seed oil products were analyzed using high-performance liquid chromatography (HPLC). Additionally, their antioxidant activities were determined.</p></sec><sec id="sec2-medicines-07-00057"><title>2. Materials and Methods</title><sec id="sec2dot1-medicines-07-00057"><title>2.1. Samples</title><p>CBD, hemp seed and rapeseed oils were purchased online as described in <xref rid="medicines-07-00057-t001" ref-type="table">Table 1</xref>.</p></sec><sec id="sec2dot2-medicines-07-00057"><title>2.2. HPLC Analysis</title><p>HPLC analyses were performed using an Alliance Waters e2695 (Waters) and Alliance Waters 2998 PDA detector. An XTerra MS C18 column (3.5 &#x000b5;m, 4.6 mm &#x000d7; 150 mm, Waters) was used with an isocratic mobile phase of water (0.1% formic acid): acetonitrile 3:7 at a flow rate of 0.8 mL/min for 30 min. The column temperature was set to 35 &#x000b0;C and sample injection volume was 10 &#x000b5;L. The chromatograms were monitored at 235 nm. The HPLC analysis for CBD detection and validation was based on previously reported methods with modification [<xref rid="B12-medicines-07-00057" ref-type="bibr">12</xref>,<xref rid="B19-medicines-07-00057" ref-type="bibr">19</xref>]. CBD and THC reference standards were obtained from Cayman Chemical, Michigan, USA and Sigma-Aldrich, USA, respectively. Standard stock solutions of CBD (100 &#x000b5;g/mL) were prepared in methanol, and calibration curves were prepared with the CBD standard at concentrations of 100, 50, 25, 12.5, 5 and 0.5 &#x000b5;g/mL (<xref ref-type="app" rid="app1-medicines-07-00057">Figure S1</xref>). Linearity was assessed by evaluating the coefficient of determination (R<sup>2</sup>). HPLC chromatographs of CBD and THC standards are shown in <xref ref-type="app" rid="app1-medicines-07-00057">Supplementary Materials</xref>. The instrumental limit of detection (LOD) values were calculated using the following formula: LOD = (3.3 &#x000d7; &#x003c3;)/m, where &#x003c3; is the residual standard deviation of the calibration curve and m is the calibration curve slope. The limit of quantification (LOQ) values were determined according to the following formula: LOQ = (10 &#x000d7; &#x003c3;)/m. The intra-day repeatability of the method was assessed by analyzing three replicates of the samples injected thrice on the same day. The relative standard deviation (RSD) of the three replicates was also calculated.</p></sec><sec id="sec2dot3-medicines-07-00057"><title>2.3. Sample Preparation for HPLC</title><p>CBD oils were diluted with methanol and injected into the HPLC system. First, 5 mL of hemp seed oil was extracted with 20 mL methanol. After solvent evaporation, the samples were heated at 100 &#x000b0;C for 2 h. Subsequently, the samples were added to methanol and injected into the HPLC system. All the analyses were performed in triplicate, and the data are expressed as mean &#x000b1; standard deviation.</p></sec><sec id="sec2dot4-medicines-07-00057"><title>2.4. Antioxidant Assay</title><p>2,2-Diphenyl-1-picrylhydrazyl (DPPH) and 2,2&#x02032;-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical-scavenging assays were performed. The oils (250 &#x000b5;L) were extracted with 1 mL methanol for 10 min with occasional shaking. After incubation, the supernatant was used as the sample solution. The DPPH assay was performed according to a previously described protocol [<xref rid="B20-medicines-07-00057" ref-type="bibr">20</xref>,<xref rid="B21-medicines-07-00057" ref-type="bibr">21</xref>]. In a total volume of 200 &#x000b5;L, 180 &#x000b5;L of 100 &#x000b5;M DPPH dissolved in methanol and 20 &#x000b5;L of the samples dissolved in methanol were incubated for 30 min at room temperature. The absorbance of the mixture was measured at 517 nm using a microplate reader (Molecular Devices SPECTRA MAX M2). The ABTS radical-scavenging activity was determined according to a previously described assay with some minor modifications [<xref rid="B21-medicines-07-00057" ref-type="bibr">21</xref>]. Briefly, 7 mM ABTS in H<sub>2</sub>O and 2.45 mM potassium persulfate were mixed in a 1:1 ratio. Then, the solution was diluted in methanol at a 1:25 ratio. In a 96-well plate, 180 &#x000b5;L of the diluted solution and 20 &#x000b5;L of each sample dissolved in methanol were mixed and incubated for 10 min at room temperature, and absorbance was measured at 734 nm. The percentage enzyme activity inhibition was calculated by comparison with the negative control: Inhibition (%) = 100 &#x000d7; (A<sub>0</sub> &#x02212; A<sub>1</sub>)/A<sub>0</sub>, where A<sub>0</sub> is the negative control absorbance and A<sub>1</sub> is the sample absorbance. For each sample with a percentage inhibition of &#x0003e;60%, the IC<sub>50</sub> values were determined from a dose&#x02013;response curve with eight different concentrations. Ascorbic acid was used as a positive control.</p></sec></sec><sec sec-type="results" id="sec3-medicines-07-00057"><title>3. Results</title><sec id="sec3dot1-medicines-07-00057"><title>3.1. HPLC Analysis of CBD and Hemp Seed Oils</title><p>Herein, two CBD and seven hemp seed oil samples were evaluated, while rapeseed oil was used as a CBD-free sample. To quantify the CBD concentration of CBD and hemp seed oils, HPLC analysis was performed. A calibration curve was constructed using CBD standards (100, 50, 25, 12.5, 5 and 0.5 &#x000b5;g/mL). The linearity plot and chromatograph are shown in the <xref ref-type="app" rid="app1-medicines-07-00057">Supplementary Materials</xref>, and the linearity coefficient of determination (R<sup>2</sup>) was 0.995. From <xref rid="medicines-07-00057-t002" ref-type="table">Table 2</xref>, the LOD, LOQ, as well as intra- and inter-day RSD were 1.5 &#x000b5;g/mL, 4.6 &#x000b5;g/mL, 4.2% and 2.4%, respectively.</p><p>Using the HPLC method, CBD and hemp seed oil samples were analyzed. Because CBD exists primarily in the carboxylated form, cannabidiol acid (CBDA), in fresh <italic>C. sativa</italic> L. plants, hemp seed oil samples were heated at 100 &#x000b0;C for 2 h to decarboxylate CBDA into CBD [<xref rid="B12-medicines-07-00057" ref-type="bibr">12</xref>]. The CBD concentration of each sample is shown in <xref ref-type="fig" rid="medicines-07-00057-f001">Figure 1</xref>. The CBD oil samples (C1 and C2) showed concentrations of 18.9 &#x000b1; 0.5 and 9.2 &#x000b1; 0.4 mg/mL, respectively, which were nearly equal to the value displayed on the product description (500 mg/30 mL and 300 mg/30 mL, respectively). Of the seven hemp oil samples tested, six contained CBD concentrations ranging from 2.0 &#x000b1; 0.1 (C6) to 20.5 &#x000b1; 0.5 (C4) &#x000b5;g/mL, and CBD was not detected in one hemp seed oil sample (C7) or rape oil sample (C9).</p></sec><sec id="sec3dot2-medicines-07-00057"><title>3.2. Biological Activities of CBD and Hemp Seed Oils</title><p>To assess the biological activities of CBD and hemp seed oils in vitro, ABTS and DPPH assays were performed (<xref rid="medicines-07-00057-t003" ref-type="table">Table 3</xref>). The DPPH and ABTS assay results indicated that antioxidant activities in the CBD oil samples were higher than those in the hemp seed oil samples. The CBD oil samples (C1 and C2) showed dose&#x02013;response DPPH scavenging activities with IC<sub>50</sub> values of 17.9 and 18.6 &#x000b5;L/mL, respectively. The CBD oil samples (C1 and C2) also showed dose&#x02013;response ABTS scavenging activities with IC<sub>50</sub> values of 2.3 and 3.6 &#x000b5;L/mL, respectively. To confirm the antioxidant activity of the CBD oil samples, the DPPH and ABTS scavenging activities were evaluated using a CBD standard. The IC<sub>50</sub> values of the CBD standard in the DPPH and ABTS assays were 584 and 92.2 &#x000b5;M, respectively. The IC<sub>50</sub> values of the CBD oil samples (C1 and C2) calculated using each concentration obtained from <xref ref-type="fig" rid="medicines-07-00057-f001">Figure 1</xref> were respectively 1075 and 522 &#x000b5;M in the DPPH assay, and 138 and 67 &#x000b5;M in the ABTS assay. These results indicated that the antioxidant potential of CBD oil could be attributed to CBD.</p></sec></sec><sec sec-type="discussion" id="sec4-medicines-07-00057"><title>4. Discussion</title><p>Herein, it was found that six of seven hemp seed oil products contained CBD, while the concentration varied by sample. Therefore, the unintended intake of CBD from hemp seed oil products might occur. Considering the adverse effects of CBD, including developmental toxicity, embryo-fatal mortality and neurotoxicity, unintended consumption of CBD should be avoided [<xref rid="B22-medicines-07-00057" ref-type="bibr">22</xref>]. The cannabinoid content in hemp seed oil products could be affected by strain, product origin and processing steps. In this study, THC was not detected in any samples. Previous reports showed that some hemp seed oil products contained cannabinoids, including CBD and THC [<xref rid="B10-medicines-07-00057" ref-type="bibr">10</xref>,<xref rid="B12-medicines-07-00057" ref-type="bibr">12</xref>]. In Japan, CBD and hemp seed oil products containing THC are strictly prohibited by law. In addition, some products are marketed without a clear distinction between CBD and hemp seed oils. Therefore, the quality control of CBD and hemp seed oil products is necessary. In the antioxidant assays, the CBD oils exhibited free radical scavenging activities in a CBD dose-dependent manner. Because the DPPH and ABTS assays are simple and rapid, antioxidant activity represents a useful marker for distinguishing between CBD and hemp seed oils. Previously, the antioxidant activities of cannabinoids and <italic>C. sativa</italic> extracts were evaluated by DPPH and ABTS assays [<xref rid="B18-medicines-07-00057" ref-type="bibr">18</xref>]. CBD and THC showed similar antioxidant activities by ABTS assay, whereas the antioxidant activity of CBD determined by DPPH assay was two-fold higher than that of THC [<xref rid="B18-medicines-07-00057" ref-type="bibr">18</xref>]. Therefore, the ratio of antioxidant activity determined by DPPH assay to that by ABTS assay might be useful information for the quality control of CBD oils to avoid contamination with THC.</p></sec><sec sec-type="conclusions" id="sec5-medicines-07-00057"><title>5. Conclusions</title><p>In this study, we analyzed the CBD contents and antioxidant activities of CBD and hemp seed oils commercially available in Japan. The CBD contents of hemp seed oils varied by sample. Because CBD oil samples exhibited strong antioxidant activities, antioxidant assays represent a useful marker for distinguishing between CBD and hemp seed oils. Our results could be applicable for the quality control of CBD and hemp seed oil products.</p></sec></body><back><app-group><app id="app1-medicines-07-00057"><title>Supplementary Materials</title><p>The following are available online at <uri xlink:href="https://www.mdpi.com/2305-6320/7/9/57/s1">https://www.mdpi.com/2305-6320/7/9/57/s1</uri>, Figure S1: (a) Linearity plot of CBD standard. (b) HPLC chromatographs of CBD standard, THC standard, and CBD oil sample (C1).</p><supplementary-material content-type="local-data" id="medicines-07-00057-s001"><media xlink:href="medicines-07-00057-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization and supervision, M.K. and R.S.; Methodology, all authors; HPLC analysis, M.K., Y.K., R.S., and S.D.; writing&#x02014;original draft preparation, M.K.; writing&#x02014;review and editing, all authors; All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no competing financial interests.</p></notes><ref-list><title>References</title><ref id="B1-medicines-07-00057"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>J.</given-names></name></person-group><article-title>The Cannabis Crop</article-title><source>Nature</source><year>2015</year><volume>525</volume><fpage>S2</fpage><lpage>S3</lpage><pub-id pub-id-type="doi">10.1038/525S2a</pub-id><?supplied-pmid 26398736?><pub-id pub-id-type="pmid">26398736</pub-id></element-citation></ref><ref id="B2-medicines-07-00057"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ElSohly</surname><given-names>M.A.</given-names></name><name><surname>Radwan</surname><given-names>M.M.</given-names></name><name><surname>Gul</surname><given-names>W.</given-names></name><name><surname>Chandra</surname><given-names>S.</given-names></name><name><surname>Galal</surname><given-names>A.</given-names></name></person-group><article-title>Phytochemistry of <italic>Cannabis Sativa</italic> L</article-title><source>Prog. Chem. Org. Nat. Prod.</source><year>2017</year><volume>103</volume><fpage>1</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">28120229</pub-id></element-citation></ref><ref id="B3-medicines-07-00057"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pertwee</surname><given-names>R.G.</given-names></name></person-group><article-title>The Diverse CB 1 and CB 2 Receptor Pharmacology of Three Plant Cannabinoids: &#x00394; 9-Tetrahydrocannabinol, Cannabidiol and &#x00394; 9-Tetrahydrocannabivarin</article-title><source>Br. J. Pharmacol.</source><year>2008</year><volume>153</volume><fpage>199</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0707442</pub-id><?supplied-pmid 17828291?><pub-id pub-id-type="pmid">17828291</pub-id></element-citation></ref><ref id="B4-medicines-07-00057"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Press</surname><given-names>C.A.</given-names></name><name><surname>Knupp</surname><given-names>K.G.</given-names></name><name><surname>Chapman</surname><given-names>K.E.</given-names></name></person-group><article-title>Parental Reporting of Response to Oral Cannabis Extracts for Treatment of Refractory Epilepsy</article-title><source>Epilepsy Behav.</source><year>2015</year><volume>45</volume><fpage>49</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.yebeh.2015.02.043</pub-id><?supplied-pmid 25845492?><pub-id pub-id-type="pmid">25845492</pub-id></element-citation></ref><ref id="B5-medicines-07-00057"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname><given-names>F.A.</given-names></name><name><surname>Aguiar</surname><given-names>D.C.</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>F.S.</given-names></name></person-group><article-title>Anxiolytic-like Effect of Cannabidiol in the Rat Vogel Conflict Test</article-title><source>Prog. Neuro-Psychopharmacol. Biol. Psychiatry</source><year>2006</year><volume>30</volume><fpage>1466</fpage><lpage>1471</lpage><pub-id pub-id-type="doi">10.1016/j.pnpbp.2006.06.004</pub-id></element-citation></ref><ref id="B6-medicines-07-00057"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campos</surname><given-names>A.C.</given-names></name><name><surname>Foga&#x000e7;a</surname><given-names>M.V.</given-names></name><name><surname>Sonego</surname><given-names>A.B.</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>F.S.</given-names></name></person-group><article-title>Cannabidiol, Neuroprotection and Neuropsychiatric Disorders</article-title><source>Pharmacol. Res.</source><year>2016</year><volume>112</volume><fpage>119</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2016.01.033</pub-id><pub-id pub-id-type="pmid">26845349</pub-id></element-citation></ref><ref id="B7-medicines-07-00057"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>VanDolah</surname><given-names>H.J.</given-names></name><name><surname>Bauer</surname><given-names>B.A.</given-names></name><name><surname>Mauck</surname><given-names>K.F.</given-names></name></person-group><article-title>Clinicians&#x02019; Guide to Cannabidiol and Hemp Oils</article-title><source>Mayo Clin. Proc.</source><year>2019</year><volume>94</volume><fpage>1840</fpage><lpage>1851</lpage><pub-id pub-id-type="doi">10.1016/j.mayocp.2019.01.003</pub-id><?supplied-pmid 31447137?><pub-id pub-id-type="pmid">31447137</pub-id></element-citation></ref><ref id="B8-medicines-07-00057"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannucci</surname><given-names>C.</given-names></name><name><surname>Navarra</surname><given-names>M.</given-names></name><name><surname>Calapai</surname><given-names>F.</given-names></name><name><surname>Spagnolo</surname><given-names>E.V.</given-names></name><name><surname>Busard&#x000f2;</surname><given-names>F.P.</given-names></name><name><surname>Cas</surname><given-names>R.D.</given-names></name><name><surname>Ippolito</surname><given-names>F.M.</given-names></name><name><surname>Calapai</surname><given-names>G.</given-names></name></person-group><article-title>Neurological Aspects of Medical Use of Cannabidiol</article-title><source>CNS Neurol. Disord. Drug Targets</source><year>2017</year><volume>16</volume><fpage>541</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.2174/1871527316666170413114210</pub-id><pub-id pub-id-type="pmid">28412918</pub-id></element-citation></ref><ref id="B9-medicines-07-00057"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Da Porto</surname><given-names>C.</given-names></name><name><surname>Decorti</surname><given-names>D.</given-names></name><name><surname>Tubaro</surname><given-names>F.</given-names></name></person-group><article-title>Fatty Acid Composition and Oxidation Stability of Hemp (<italic>Cannabis Sativa</italic> L.) Seed Oil Extracted by Supercritical Carbon Dioxide</article-title><source>Ind. Crops Prod.</source><year>2012</year><volume>36</volume><fpage>401</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2011.09.015</pub-id></element-citation></ref><ref id="B10-medicines-07-00057"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrovi&#x00107;</surname><given-names>M.</given-names></name><name><surname>Debeljak</surname><given-names>&#x0017d;.</given-names></name><name><surname>Kezi&#x00107;</surname><given-names>N.</given-names></name><name><surname>D&#x0017e;idara</surname><given-names>P.</given-names></name></person-group><article-title>Relationship between Cannabinoids Content and Composition of Fatty Acids in Hempseed Oils</article-title><source>Food Chem.</source><year>2015</year><volume>170</volume><fpage>218</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2014.08.039</pub-id><pub-id pub-id-type="pmid">25306338</pub-id></element-citation></ref><ref id="B11-medicines-07-00057"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwasaki</surname><given-names>K.</given-names></name><name><surname>Takayama</surname><given-names>S.</given-names></name></person-group><article-title>Hemp Seed Pill May Improve Chronic Constipation of the Elderly and Reduce the Burden of Helpers</article-title><source>J. Fam. Med. Prim. Care</source><year>2019</year><volume>8</volume><fpage>2150</fpage><pub-id pub-id-type="doi">10.4103/jfmpc.jfmpc_384_19</pub-id><?supplied-pmid 31334198?><pub-id pub-id-type="pmid">31334198</pub-id></element-citation></ref><ref id="B12-medicines-07-00057"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Citti</surname><given-names>C.</given-names></name><name><surname>Pacchetti</surname><given-names>B.</given-names></name><name><surname>Vandelli</surname><given-names>M.A.</given-names></name><name><surname>Forni</surname><given-names>F.</given-names></name><name><surname>Cannazza</surname><given-names>G.</given-names></name></person-group><article-title>Analysis of Cannabinoids in Commercial Hemp Seed Oil and Decarboxylation Kinetics Studies of Cannabidiolic Acid (CBDA)</article-title><source>J. Pharm. Biomed. Anal.</source><year>2018</year><volume>149</volume><fpage>532</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2017.11.044</pub-id><?supplied-pmid 29182999?><pub-id pub-id-type="pmid">29182999</pub-id></element-citation></ref><ref id="B13-medicines-07-00057"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsunaga</surname><given-names>T.</given-names></name><name><surname>Watanabe</surname><given-names>K.</given-names></name><name><surname>Yoshimura</surname><given-names>H.</given-names></name><name><surname>Yamamoto</surname><given-names>I.</given-names></name></person-group><article-title>Quantitative Analysis and Pharmaco-Toxicity of Cannabinoids in Commercially Available Cannabis Seeds</article-title><source>Yakugaku Zasshi</source><year>1998</year><volume>118</volume><fpage>408</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1248/yakushi1947.118.9_408</pub-id><?supplied-pmid 9779001?><pub-id pub-id-type="pmid">9779001</pub-id></element-citation></ref><ref id="B14-medicines-07-00057"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>E.B.</given-names></name><name><surname>Marcu</surname><given-names>J.</given-names></name></person-group><article-title>Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads</article-title><source>Adv. Pharmacol.</source><year>2017</year><volume>80</volume><fpage>67</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">28826544</pub-id></element-citation></ref><ref id="B15-medicines-07-00057"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>X.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Dos Santos Passos</surname><given-names>C.</given-names></name><name><surname>Nurisso</surname><given-names>A.</given-names></name><name><surname>Simoes-Pires</surname><given-names>C.A.</given-names></name><name><surname>Ji</surname><given-names>M.</given-names></name><name><surname>Lou</surname><given-names>H.</given-names></name><name><surname>Fan</surname><given-names>P.</given-names></name></person-group><article-title>Characterization of Lignanamides from Hemp (<italic>Cannabis Sativa</italic> L.) Seed and Their Antioxidant and Acetylcholinesterase Inhibitory Activities</article-title><source>J. Agric. Food Chem.</source><year>2015</year><volume>63</volume><fpage>10611</fpage><lpage>10619</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.5b05282</pub-id><pub-id pub-id-type="pmid">26585089</pub-id></element-citation></ref><ref id="B16-medicines-07-00057"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nissen</surname><given-names>L.</given-names></name><name><surname>Zatta</surname><given-names>A.</given-names></name><name><surname>Stefanini</surname><given-names>I.</given-names></name><name><surname>Grandi</surname><given-names>S.</given-names></name><name><surname>Sgorbati</surname><given-names>B.</given-names></name><name><surname>Biavati</surname><given-names>B.</given-names></name><name><surname>Monti</surname><given-names>A.</given-names></name></person-group><article-title>Characterization and Antimicrobial Activity of Essential Oils of Industrial Hemp Varieties (<italic>Cannabis Sativa</italic> L.)</article-title><source>Fitoterapia</source><year>2010</year><volume>81</volume><fpage>413</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2009.11.010</pub-id><pub-id pub-id-type="pmid">19969046</pub-id></element-citation></ref><ref id="B17-medicines-07-00057"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zengin</surname><given-names>G.</given-names></name><name><surname>Menghini</surname><given-names>L.</given-names></name><name><surname>Di Sotto</surname><given-names>A.</given-names></name><name><surname>Mancinelli</surname><given-names>R.</given-names></name><name><surname>Sisto</surname><given-names>F.</given-names></name><name><surname>Carradori</surname><given-names>S.</given-names></name><name><surname>Cesa</surname><given-names>S.</given-names></name><name><surname>Fraschetti</surname><given-names>C.</given-names></name><name><surname>Filippi</surname><given-names>A.</given-names></name><name><surname>Angiolella</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Chromatographic Analyses, In Vitro Biological Activities, and Cytotoxicity of <italic>Cannabis Sativa</italic> L. Essential Oil: A Multidisciplinary Study</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>3266</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23123266</pub-id></element-citation></ref><ref id="B18-medicines-07-00057"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hacke</surname><given-names>A.C.M.</given-names></name><name><surname>Lima</surname><given-names>D.</given-names></name><name><surname>de Costa</surname><given-names>F.</given-names></name><name><surname>Deshmukh</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Chow</surname><given-names>A.M.</given-names></name><name><surname>Marques</surname><given-names>J.A.</given-names></name><name><surname>Pereira</surname><given-names>R.P.</given-names></name><name><surname>Kerman</surname><given-names>K.</given-names></name></person-group><article-title>Probing the antioxidant activity of &#x00394;9-tetrahydrocannabinol and cannabidiol in <italic>Cannabis sativa</italic> extracts</article-title><source>Analyst</source><year>2019</year><volume>144</volume><fpage>4952</fpage><lpage>4961</lpage><pub-id pub-id-type="doi">10.1039/C9AN00890J</pub-id><pub-id pub-id-type="pmid">31318364</pub-id></element-citation></ref><ref id="B19-medicines-07-00057"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandrioli</surname><given-names>M.</given-names></name><name><surname>Tura</surname><given-names>M.</given-names></name><name><surname>Scotti</surname><given-names>S.</given-names></name><name><surname>Toschi</surname><given-names>G.T.</given-names></name></person-group><article-title>Fast Detection of 10 Cannabinoids by RP-HPLC-UV Method in <italic>Cannabis sativa</italic> L.</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>2113</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24112113</pub-id></element-citation></ref><ref id="B20-medicines-07-00057"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takao</surname><given-names>K.</given-names></name><name><surname>Toda</surname><given-names>K.</given-names></name><name><surname>Saito</surname><given-names>T.</given-names></name><name><surname>Sugita</surname><given-names>Y.</given-names></name></person-group><article-title>Synthesis of Amide and Ester Derivatives of Cinnamic Acid and Its Analogs: Evaluation of Their Free Radical Scavenging and Monoamine Oxidase and Cholinesterase Inhibitory Activities</article-title><source>Chem. Pharm. Bull.</source><year>2017</year><volume>65</volume><fpage>1020</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.1248/cpb.c17-00416</pub-id></element-citation></ref><ref id="B21-medicines-07-00057"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atolani</surname><given-names>O.</given-names></name><name><surname>Oguntoye</surname><given-names>H.</given-names></name><name><surname>Areh</surname><given-names>E.T.</given-names></name><name><surname>Adeyemi</surname><given-names>O.S.</given-names></name><name><surname>Kambizi</surname><given-names>L.</given-names></name></person-group><article-title>Chemical Composition, Anti-Toxoplasma, Cytotoxicity, Antioxidant, and Anti-Inflammatory Potentials of <italic>Cola Gigantea</italic> Seed Oil</article-title><source>Pharm. Biol.</source><year>2019</year><volume>57</volume><fpage>154</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1080/13880209.2019.1577468</pub-id><?supplied-pmid 30905238?><pub-id pub-id-type="pmid">30905238</pub-id></element-citation></ref><ref id="B22-medicines-07-00057"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huestis</surname><given-names>M.A.</given-names></name><name><surname>Solimini</surname><given-names>R.</given-names></name><name><surname>Pichini</surname><given-names>S.</given-names></name><name><surname>Pacifici</surname><given-names>R.</given-names></name><name><surname>Carlier</surname><given-names>J.</given-names></name><name><surname>Busard&#x000f2;</surname><given-names>F.P.</given-names></name></person-group><article-title>Cannabidiol Adverse Effects and Toxicity</article-title><source>Curr. Neuropharmacol.</source><year>2019</year><volume>17</volume><fpage>974</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.2174/1570159X17666190603171901</pub-id><?supplied-pmid 31161980?><pub-id pub-id-type="pmid">31161980</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="medicines-07-00057-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>CBD concentrations in CBD oil (<bold>a</bold>) and hemp seed oil (<bold>b</bold>) samples.</p></caption><graphic xlink:href="medicines-07-00057-g001"/></fig><table-wrap id="medicines-07-00057-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">medicines-07-00057-t001_Table 1</object-id><label>Table 1</label><caption><p>CBD and hemp seed oil samples in this study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Product</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Product Origin</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">C1</td><td align="center" valign="middle" rowspan="1" colspan="1">CBD oil</td><td align="center" valign="middle" rowspan="1" colspan="1">USA</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C2</td><td align="center" valign="middle" rowspan="1" colspan="1">CBD oil</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C3</td><td align="center" valign="middle" rowspan="1" colspan="1">Hemp seed oil</td><td align="center" valign="middle" rowspan="1" colspan="1">Australia</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C4</td><td align="center" valign="middle" rowspan="1" colspan="1">Hemp seed oil</td><td align="center" valign="middle" rowspan="1" colspan="1">New Zealand</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C5</td><td align="center" valign="middle" rowspan="1" colspan="1">Hemp seed oil</td><td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C6</td><td align="center" valign="middle" rowspan="1" colspan="1">Hemp seed oil</td><td align="center" valign="middle" rowspan="1" colspan="1">Germany</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C7</td><td align="center" valign="middle" rowspan="1" colspan="1">Hemp seed oil</td><td align="center" valign="middle" rowspan="1" colspan="1">Germany</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C8</td><td align="center" valign="middle" rowspan="1" colspan="1">Hemp seed oil</td><td align="center" valign="middle" rowspan="1" colspan="1">Canada</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rapeseed oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Japan</td></tr></tbody></table></table-wrap><table-wrap id="medicines-07-00057-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">medicines-07-00057-t002_Table 2</object-id><label>Table 2</label><caption><p>Parameters for method validation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Factors</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Results</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Equation</td><td align="center" valign="middle" rowspan="1" colspan="1">y = 18600x &#x02212; 23348</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">R<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.995</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">LOD (&#x000b5;g/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">LOQ (&#x000b5;g/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">RSD (Intra-Day)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.2%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RSD (Inter-Day)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.4%</td></tr></tbody></table></table-wrap><table-wrap id="medicines-07-00057-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">medicines-07-00057-t003_Table 3</object-id><label>Table 3</label><caption><p>Biological activities of CBD and hemp seed oils.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Sample</th><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Antioxidant Activity</th></tr><tr><th colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">DPPH</th><th colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">ABTS</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sample Conc.<break/>(25 &#x000b5;L/mL)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC<sub>50</sub><break/>(CBD)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sample Conc.<break/>(25 &#x000b5;L/mL)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC<sub>50</sub><break/>(CBD)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">C1</td><td align="center" valign="middle" rowspan="1" colspan="1">64.8 &#x000b1; 0.8%</td><td align="center" valign="middle" rowspan="1" colspan="1">17.9 &#x000b5;L/mL<break/>(1075 &#x000b5;M)</td><td align="center" valign="middle" rowspan="1" colspan="1">90.5 &#x000b1; 0.1%</td><td align="center" valign="middle" rowspan="1" colspan="1">2.3 &#x000b5;L/mL<break/>(138 &#x000b5;M)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C2</td><td align="center" valign="middle" rowspan="1" colspan="1">63.2 &#x000b1; 1.4%</td><td align="center" valign="middle" rowspan="1" colspan="1">18.6 &#x000b5;L/mL<break/>(522 &#x000b5;M)</td><td align="center" valign="middle" rowspan="1" colspan="1">90.3 &#x000b1; 0.1%</td><td align="center" valign="middle" rowspan="1" colspan="1">3.6 &#x000b5;L/mL<break/>(67 &#x000b5;M)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C3</td><td align="center" valign="middle" rowspan="1" colspan="1">12.7 &#x000b1; 0.8%</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">28.2 &#x000b1; 2.4%</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C4</td><td align="center" valign="middle" rowspan="1" colspan="1">23.2 &#x000b1; 1.0%</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">47.8 &#x000b1; 2.0%</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C5</td><td align="center" valign="middle" rowspan="1" colspan="1">19.8 &#x000b1; 0.4%</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">21.8 &#x000b1; 1.3%</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C6</td><td align="center" valign="middle" rowspan="1" colspan="1">11.1 &#x000b1; 0.6%</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">27.3 &#x000b1; 1.1%</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C7</td><td align="center" valign="middle" rowspan="1" colspan="1">1.3 &#x000b1; 0.8%</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">2.8 &#x000b1; 1.2%</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C8</td><td align="center" valign="middle" rowspan="1" colspan="1">11.6 &#x000b1; 1.1%</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">26.9 &#x000b1; 1.0%</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.5 &#x000b1; 0.6%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.6 &#x000b1; 1.9%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ascorbic Acid</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">38.0 &#x000b5;M</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">11.3 &#x000b5;M</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CBD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">584 &#x000b5;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">92.2 &#x000b5;M</td></tr></tbody></table></table-wrap></floats-group></article>